RSS03-2010 (March 2010)

Pregnancy is Not Detrimental to the Melanoma Patient with Clinically Localized Disease

| March 5, 2010 | 0 Comments

Mary S. Brady, MD; Memorial Sloan-Kettering Cancer Center, New York, New York; Nikki S. Noce, New York University Medical Center, New York, New York Disclosure: The authors report no relevant conflicts of interest.

Continue Reading

The Use of a Contact Cooling Device to Reduce Pain and Ecchymosis Associated With Dermal Filler Injections

| March 5, 2010 | 0 Comments

Mark S. Nestor, MD, PhD, Center for Clinical and Cosmetic Research, Aventura, Florida; Glynis R. Ablon, MD, Ablon Skin Institute, Manhattan Beach, California; Mark A. Stillman, PhD, Center for Clinical and Cosmetic Research, Aventura, Florida Disclosure: Dr. Nestor has received research grant support from and is a consultant and speaker for Medicis. Dr. Ablon has [...]

Continue Reading

Topical Botulinum Toxin

| March 5, 2010 | 0 Comments

Ashley Collins, MD; Department of Biochemistry, North Carolina State University; Adnan Nasir, MD, Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina Abstract Nanotechnology is a rapidly growing discipline that capitalizes on the unique properties of matter engineered on the nanoscale. Vehicles incorporating nanotechnology have led to great strides in drug delivery, allowing [...]

Continue Reading

5-Aminolevulinic Acid-based Photodynamic Intense Pulsed Light Therapy Shows Better Effects in the Treatment of Skin Photoaging in Asian Skin: A Prospective, Single-blinded, Controlled Trial

| March 5, 2010 | 0 Comments

Gao Yang, MD, Laser Center, Jinshan Hospital, Fudan University, Shanghai, China; Leihong Flora Xiang, MD, PhD Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China; Michael H. Gold, MD, Gold Skin Care Center, Tennessee Clinical Research Center, Nashville, Tennesee; Vanderbilt University School of Medicine, Department of Dermatology; Vanderbilt University School of Medicine, School of Nursing, [...]

Continue Reading

Questions • Challenges • Controversies: How Clinically Relevant is Dapsone-related Peripheral Neuropathy? An Overview of Available Data with Emphasis on Clinical Recognition

| March 5, 2010 | 1 Comment

Morgan McCarty (MS4); James Q. Del Rosso, DO, FAOCD Section Editor: James Q. Del Rosso, DO, FAOCD Ms. McCarty (MS4) is from Midwestern University AZCOM, Glendale, Arizona. Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Ms. McCarty and Dr. Del Rosso report no relevant conflicts of interest.

Continue Reading